231 related articles for article (PubMed ID: 30922116)
1. Design and sample size considerations for Alzheimer's disease prevention trials using multistate models.
Brookmeyer R; Abdalla N
Clin Trials; 2019 Apr; 16(2):111-119. PubMed ID: 30922116
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Multistate models and lifetime risk estimation: Application to Alzheimer's disease.
Brookmeyer R; Abdalla N
Stat Med; 2019 Apr; 38(9):1558-1565. PubMed ID: 30511460
[TBL] [Abstract][Full Text] [Related]
4. Choosing Alzheimer's disease prevention clinical trial populations.
Grill JD; Monsell SE
Neurobiol Aging; 2014 Mar; 35(3):466-71. PubMed ID: 24119546
[TBL] [Abstract][Full Text] [Related]
5. Minimizing the Sample Sizes of Clinical Trials on Preclinical and Early Symptomatic Stage of Alzheimer Disease.
Luo J; Weng H; Morris JC; Xiong C
J Prev Alzheimers Dis; 2018; 5(2):110-119. PubMed ID: 29616704
[TBL] [Abstract][Full Text] [Related]
6. Use of High-Frequency In-Home Monitoring Data May Reduce Sample Sizes Needed in Clinical Trials.
Dodge HH; Zhu J; Mattek NC; Austin D; Kornfeld J; Kaye JA
PLoS One; 2015; 10(9):e0138095. PubMed ID: 26379170
[TBL] [Abstract][Full Text] [Related]
7. Estimation of lifetime risks of Alzheimer's disease dementia using biomarkers for preclinical disease.
Brookmeyer R; Abdalla N
Alzheimers Dement; 2018 Aug; 14(8):981-988. PubMed ID: 29802030
[TBL] [Abstract][Full Text] [Related]
8. Evolving early (pre-dementia) Alzheimer's disease trials: suit the outcomes to the population and study design.
Doody RS
J Nutr Health Aging; 2010 Apr; 14(4):299-302. PubMed ID: 20306000
[TBL] [Abstract][Full Text] [Related]
9. 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Flicker L; Bonfill Cosp X
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012884. PubMed ID: 29164602
[TBL] [Abstract][Full Text] [Related]
10. 18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Bonfill Cosp X; Flicker L
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012216. PubMed ID: 29164603
[TBL] [Abstract][Full Text] [Related]
11. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
[TBL] [Abstract][Full Text] [Related]
12. The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer's disease.
Rafii MS; Sperling RA; Donohue MC; Zhou J; Roberts C; Irizarry MC; Dhadda S; Sethuraman G; Kramer LD; Swanson CJ; Li D; Krause S; Rissman RA; Walter S; Raman R; Johnson KA; Aisen PS
Alzheimers Dement; 2023 Apr; 19(4):1227-1233. PubMed ID: 35971310
[TBL] [Abstract][Full Text] [Related]
13. Continuing education for the prevention of mild cognitive impairment and Alzheimer's-type dementia: a systematic review protocol.
Matyas N; Auer S; Gisinger C; Kil M; Keser Aschenberger F; Klerings I; Gartlehner G
Syst Rev; 2017 Aug; 6(1):157. PubMed ID: 28789697
[TBL] [Abstract][Full Text] [Related]
14. The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.
Ayutyanont N; Langbaum JB; Hendrix SB; Chen K; Fleisher AS; Friesenhahn M; Ward M; Aguirre C; Acosta-Baena N; Madrigal L; Muñoz C; Tirado V; Moreno S; Tariot PN; Lopera F; Reiman EM
J Clin Psychiatry; 2014 Jun; 75(6):652-60. PubMed ID: 24816373
[TBL] [Abstract][Full Text] [Related]
15. The Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD): Experience from the First 3 Years.
Walter S; Langford OG; Clanton TB; Jimenez-Maggiora GA; Raman R; Rafii MS; Shaffer EJ; Sperling RA; Cummings JL; Aisen PS
J Prev Alzheimers Dis; 2020; 7(4):234-241. PubMed ID: 32920625
[TBL] [Abstract][Full Text] [Related]
16. Souvenaid for Alzheimer's disease.
Burckhardt M; Watzke S; Wienke A; Langer G; Fink A
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD011679. PubMed ID: 33320335
[TBL] [Abstract][Full Text] [Related]
17. European Prevention of Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS): study protocol.
Solomon A; Kivipelto M; Molinuevo JL; Tom B; Ritchie CW;
BMJ Open; 2019 Feb; 8(12):e021017. PubMed ID: 30782589
[TBL] [Abstract][Full Text] [Related]
18. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
[TBL] [Abstract][Full Text] [Related]
19. Psychotherapeutic interventions in individuals at risk for Alzheimer's dementia: a systematic review.
Rostamzadeh A; Kahlert A; Kalthegener F; Jessen F
Alzheimers Res Ther; 2022 Jan; 14(1):18. PubMed ID: 35101105
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
